Hybrid PET/CT in Cancer Patients

Rambam Health Care Campus45 enrolled

Overview

The purpose of the present study is to assess the role of hybrid PET/CT imaging diagnosis of active malignancy in cancer patients with rising tumor markers after treatment and in the diagnosis of primary tumor in patients with metastatic cancer of unknown origin. The clinical impact of PET/CT in the management and treatment of these two groups of cancer patients will be evaluated

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

NONE

Enrollment

Conditions

Cancer

Interventions

PET/CT imagingDEVICE

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Cancer patients in complete remission after treatment, with serial elevation of serum tumor markers and negative CT or other conventional imaging test. * Patients with newly diagnosed metastatic cancer with unknown primary tumor * Glucose levels below 150-200 * Patient signed informed consent Exclusion Criteria: * Pregnant or lactating women * Patient unable or not willing to tolerate the test until its completion * One or more of the inclusion criteria is not fulfilled

Locations (1)

Rambam Medical Center

Haifa, Israel

Outcomes

Primary Outcomes

the impact of the imaging modality on patient management

Secondary Outcomes

the impact of the imaging modality on patient management

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.